Several studies showed that chronic pain causes reorganization and functional alterations of supraspinal brain regions. The nociceptin-NOP receptor system is one of the major systems involved in pain control and much evidence also suggested its implication in stress, anxiety and depression. Therefore, we investigated the nociceptin-NOP system alterations in selected brain regions in a neuropathic pain murine model. Fourteen days after the common sciatic nerve ligature, polymerase chain reaction (PCR) analysis indicated a significant decrease of pronociceptin and NOP receptor mRNA levels in the thalamus; these alterations could contribute to the decrease of the thalamic inhibitory function reported in neuropathic pain condition. Nociceptin peptide and NOP mRNA increased in the anterior cingulate cortex (ACC) and not in the somatosensory cortex, suggesting a peculiar involvement of this system in pain regulating circuitry. Similarly to the ACC, an increase of nociceptin peptide levels was observed in the amygdala. Finally, the pronociceptin and NOP mRNAs decrease observed in the hypothalamus reflects the lack of hypothalamus-pituitary-adrenal axis activation, already reported in neuropathic pain models. Our data indicate that neuropathic pain conditions affect the supraspinal nociceptin-NOP system which is also altered in regions known to play a role in emotional aspects of pain.
Peripheral nerve injury can develop into neuropathic pain conditions characterized by a painful threshold reduction (hyperalgesia) and a painful response to a usually innocuous stimulus (allodynia) suggesting the simultaneous peripheral and central alterations of neuronal transmission (Costigan et al. 2009 ).
The involvement of the nociceptin/orphanin FQ (N/OFQ)-NOP system in pain responses has been well established although its function in the modulation of pain conditions still remains controversial (Heinricher 2003; Khroyan et al. 2011; Mika et al. 2011; Mogil & Pasternak 2001; Schröder et al. 2014) . In fact, N/OFQ peptide may evoke pronociceptive effects when administered at supraspinal level, whereas it has an antinociceptive action at spinal level (Heinricher 2003) . However, differences arise depending not only on the targeted neuraxis level but also on the doses, different pain states (Bertorelli et al. 1999; Hao et al. 1998; Hara et al. 1997; Kiguchi et al. 2016; Schiene et al. 2015; Sukhtankar et al. 2013 ) and animal species (Ding et al. 2015; Ko & Naughton 2009 ).
Alterations of the N/OFQ-NOP system have been observed during neuropathic pain conditions. Notably, in the spinal cord and in dorsal root ganglia of rats subjected to the sciatic nerve chronic constriction injury (CCI), an upregulation of prepro-N/OFQ and NOP receptor mRNA levels has been reported (Briscini et al. 2002; Liu et al. 2012) . Moreover, after spinal nerve ligation and CCI significant alterations of N/OFQ-NOP system were observed in specific brain regions involved in pain modulation (Ma et al. 2005; Sun et al. 2001) .
In addition to nociceptive behavior, several studies proposed the involvement of the N/OFQ-NOP system in mood disorders (Köster et al. 1999; Witkin et al. 2014) . In particular, the exposure to stress produces alterations of this neuropeptidergic system in limbic regions, where N/OFQ has been reported to exert anxiolytic-like effects by counteracting the anxiogenic-like actions of the corticotropin releasing factor (CRF; Ciccocioppo et al. 2001 Ciccocioppo et al. , 2002 Filaferro et al. 2014) .
The clinical reported comorbidity between chronic pain states and mood alterations may suggest the existence of common signaling pathways underlying these pathological conditions (Doan et al. 2015; Von Korff & Simon 1996) . In fact, chronic neuropathic pain induces reorganization and functional changes (Narita et al. 2006) in cortical and subcortical structures (Apkarian et al. 2004; Baliki et al. 2006; Ji et al. 2010) related to the cognitive and emotional control of pain. Human neuroimaging studies showed that brain regions commonly dysregulated in mood disorders (Bushnell et al. 2013; Doan et al. 2015) are also activated by pain and noxious stimuli (Apkarian et al. 2005) . For example, a hypermetabolism of the anterior cingulate cortex (ACC) was documented in the pathophysiology of depression (Drevets 2001) , and during painful experiences the activation of these cortical neurons was observed (Qu et al. 2011) . Similar to the ACC, also limbic regions including the amygdala (AMY) are involved in emotional, affective and cognitive functions as well as in the regulation of descending pain control pathway (Veinante et al. 2013) .
Based on these observations, we investigated whether specific alterations of the N/OFQ-NOP system may occur in different supraspinal CNS regions at 14 days after the CCI surgery, when significant and persistent signs of neuropathic pain are present. To this end the pronociceptin (pN/OFQ) and NOP receptor gene expression as well as the N/OFQ peptide levels were investigated in the brainstem (BS), thalamus (TH), ACC, somatosensory cortex (SSC), AMY and hypothalamus (HYP), given their role in the supraspinal transmission and modulation of pain.
Materials and methods

Animals
Adult male Swiss mice (ICR/CD-1 ® , Harlan Lab., Udine, Italy) weighing 20-30 g at the beginning of the experiment were housed four per cage in a temperature-and humidity-controlled room under a constant 12 h light/dark cycle (lights on at 0700 h) and with standard lab chow and tap water available ad libitum. Mice were allowed to acclimate for at least 1 week before the start of the experiments. All experiments were carried out in accordance with the European Communities Council Directive of 24 November 1986 (86/609/EEC), National (Ministry of Health, Italy) laws and policies (authorization number 139/2012-B) and with the International Association for the Study of Pain guidelines. Care was taken to minimize the number of animals and to avoid animal stress and discomfort during handling and procedures. This study has been approved by the 'Ethic Scientific Committee for the Animal Experiments' of the University of Bologna.
Surgical procedures
Mice were subjected to a right sciatic nerve lesion, according to the CCI model (Bennett & Xie 1988 ) adapted for mouse (Zhao et al. 2012) . Briefly, mice were anesthetized with a mixture of sodium pentobarbital and chloral hydrate (30 and 130 mg/kg intraperitoneal injection) and three loose ligatures were tied around the common sciatic nerve exposed at the level of the mid-thigh, proximal to the trifurcation of the nerve. Sham-operated mice, subjected to sciatic nerve exposure without ligature, were used as controls. A total of 24 mice (12 injured and 12 sham operated) were used; they were randomly assigned to gene expression analysis (6 mice per group) or peptide levels determination (6 mice per group) and all of them were subjected to behavioral tests.
Behavioral tests
The occurrence and development of behavioral signs of neuropathic pain were assessed by the plantar test (heat hyperalgesia; Hargreaves et al. 1988 ) and the acetone test (cold allodynia; Caspani et al. 2009 ) at different time points: before (0), 3, 7 and 14 days after the sciatic nerve lesion. Behavioral tests were conducted by experimenters blind to group assignment. For each behavioral tests mice were tested three times at 5 min intervals; no significant difference among the three independent measurement were observed.
Plantar test
Paw withdrawal latencies to low intensity heat stimuli were measured by the plantar test (Hargreaves et al. 1988) . Briefly, animals were placed in the test chambers (Ugo Basile Algesiometer, Varese, Italy) 15 min prior to measurements to allow acclimation; the beam intensity was set to produce a baseline threshold of approximately 10 seconds and a 30 seconds cut-off time was adopted. Paw withdrawal thresholds were recorded automatically.
Acetone test
Two hours after the last plantar test assessment, the acetone test was used to investigate the presence of thermal allodynia conditions. Mice were placed in plexiglas cages and, after about 15 min of acclimation, acetone (40 μl) was applied to the dorsal hind paw ipsilateral to the injury. The evoked behavioral response was recorded by means of an arbitrary score as follows: 0: no response; 0.5: licking response; 1: flinching and brushing of the paw; 2: strong flinching; 3: strong flinching and licking (Caspani et al. 2009 ). The observation was carried out during the 30 seconds following acetone application.
Tissue collection
Four hours after the behavioral tests, on day 14, animals were sacrificed and the following brain areas were rapidly removed and quickly frozen on dry ice: BS, TH, ACC, SSC, AMY and HYP. Brains were placed into an ice-cold matrix with 1 mm coronal section slice intervals. The ACC and SSC were punched from slices taken from 0 mm (bregma) to + 1 mm; AMY was punched from slices taken from 0 mm (bregma) to -1 mm. Brainstem, TH and HYP were removed by gross dissection. Brains were dissected under stereomicroscope in accordance with mouse brain atlas (Paxinos & Franklin 2001) . Tissues were stored at −80 ∘ C until analysis.
Real-time quantitative PCR
Total RNA was extracted according to the method of Chomczynski and Sacchi (1987) ; each sample was subjected to DNase treatment and converted to cDNA with the GeneAmp RNA PCR kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's protocol. Real-time quantitative PCR analysis was performed on a StepOne Real-Time PCR System (Applied Biosystems) using 10 μl of SYBR ® Green PCR MasterMix (Applied Biosystems); each sample was run in triplicate. Relative expression of different gene transcripts was calculated by the Delta-Delta Ct (DDCt) method and converted to relative expression ratio (2-DDCt) for statistical analysis (Livak & Schmittgen 2001) . All data were normalized to the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The specificity of each PCR product was determined by melting curve analysis constructed in the range of 60-95 ∘ C (Lyon 2001) . The primers used for PCR amplification were designed using Primer 3 and are: pN/OFQ Forward 5
Radioimmunoassay
Tissue samples were sonicated in 10 volumes (v/wt) of 1 M acetic acid at 90 ∘ C and then incubated at this temperature for 10 min. After centrifugation, the supernatants were separated, mixed with an equal volume of trifluoroacetic acid (1%, v/v) and then extracted with C18 microcolumns (SEPCOL-1; Bachem, St. Helens, UK) as already described (Aparicio et al. 2004) . Each sample was then lyophilized and stored at −80 ∘ C until radioimmunoassay (RIA).
Immunoreactive N/OFQ (ir-N/OFQ) present in tissue extracts was measured by a specific RIA according to a validated procedure (Marti et al. 2010) . Lyophilized extracts were reconstituted with 150 μl of methanol 0.1% HCl (1/1) and assayed in duplicate. Aliquots of 25 μl were mixed with 100 μl of [ 125 I]-N/OFQ (Bachem) and 100 μl of antiserum (96:2+; kindly supplied by Prof. I. Nylander, Uppsala University, Sweden). The antiserum was used at the appropriate dilution to give 30-34% binding of the added [ 125 I]-N/OFQ (approximately 5000 cpm). The labeled peptide and the antiserum were diluted in a RIA buffer containing 0.15 M NaCl, 0.02% sodium azide, 0.1% gelatin, 0.1% Triton X-100 and 0.1% BSA in a 0.05 M sodium phosphate buffer (pH 7.4). Radioimmunoassay tubes were incubated at 4 ∘ C for 24 h. A charcoal slurry (1 ml/tube) was used to separate free and antibody-bound peptide (15% horse serum, 3% charcoal, 0.3% dextran in RIA buffer). Bound peptide was separated by centrifugation (5000 g at 4 ∘ C), and 1 ml aliquots of the supernatants were counted for 1 min on a Beckman 5500 gamma counter (Beckman, Fullerton, CA, USA). The detection limit of the RIA assay was 1-2 fmol/tube. The intra-assay and inter-assay coefficients of variation were < 5%.
Statistical analysis
Plantar test data were statistically analyzed by two-way repeated measures ANOVA and F -values reaching significance were further analyzed by Bonferroni post-hoc test. Acetone test results were analyzed by Mann-Whitney U-test. Gene expression and RIA data were analyzed by Student's t-test. Results are expressed as mean ± SEM. The threshold of statistical significance was set at a P value < 0.05. Statistical analysis was performed using the GraphPad Prism software v. 5 (GraphPad software, San Diego, CA, USA).
Results
Behavioral tests
In the plantar test (Fig. 1a) , significantly lower paw withdrawal latencies were observed in the CCI mice compared to sham-operated controls, at day 3 (4.11 ± 0.40 vs. 11.98 ± 2.16; P < 0.001), 7 (2.91 ± 0.41 vs. 13.79 ± 2.18; P < 0.001) and 14 (2.32 ± 0.26 vs. 10.44 ± 0.48; P < 0.001; time: F 3,66 = 4.012, df = 3; surgery: F 1,22 = 55.54, df = 1). There was also a significant surgery × time interaction (F 3,66 = 10.02; P < 0.001).
In addition, at 3 (0.71 ± 0.04 vs. 0.05 ± 0.02; sum of ranks = 78.22, U = 0; P < 0.001), 7 (2.03 ± 0.26 vs. 0.39 ± 0.12; sum of ranks = 84.216, U = 6; P < 0.001) and 14 (1.86 ± 0.30 vs. 0.07 ± 0.02; sum of ranks = 96 204, U = 18; P < 0.001) days after surgery sciatic nerve injured animals exhibited thermal allodynia compared to the sham group (Fig. 1b) .
pN/OFQ and NOP gene expression
Fourteen days after nerve injury, in the presence of overt signs of neuropathic pain, alterations of N/OFQ system gene expression were ascertained in different supraspinal areas of CCI animals, in comparison with sham-operated controls.
In particular, nerve-injured mice showed a significant decrease of pN/OFQ mRNA in the TH (CCI group = 0.58 ± 0.06 vs. sham mice = 1.00 ± 0.09; t = 4.00, df = 9; P < 0.01; Fig. 2d) . Similarly a significant downregulation of pN/OFQ gene expression was observed in the HYP (CCI group = 0.60 ± 0.04 vs. sham mice = 1.00 ± 0.06; t = 5.66, df = 9; P < 0.001; Fig. 4d ). Significant changes of pN/OFQ were not detected in the BS (Fig. 2a) , the ACC (Fig. 3a) , the SSC (Fig. 3d ) and the AMY (Fig. 4a) .
Similarly to what observed for pN/OFQ mRNA, also NOP receptor gene expression was significantly decreased in the same brain areas of CCI animals compared to sham-operated controls (TH: 0.72 ± 0.09 vs. 1.00 ± 0.05; t = 2.53, df = 9; P < 0.05 and HYP: 0.70 ± 0.10 vs. 1.00 ± 0.07, t = 2.45, df = 9; P < 0.05; Figs. 2e and 4e, respectively). Conversely, NOP receptor mRNA was increased in the ACC of the nerve-injured animals (CCI group = 1.52 ± 0.10 vs. sham mice = 1.00 ± 0.12; t = 3.27, df = 9; P < 0.01; Fig. 3b) . Finally, the NOP receptor gene expression did not show significant alterations in the BS (Fig. 2b) , the SSC (Fig. 3e ) and the AMY (Fig. 4b ). Time-course development of hyperalgesia and allodynia in CCI mice compared to sham-operated animals (n = 6 per group). (a) Plantar test: the paw withdrawal latencies were recorded before (day 0, baseline) and at days 3, 7 and 14 after surgery. (b) Acetone test: cold allodynia was measured by a response score (0 = no response, 0.5 = licking, 1 = flinching and brushing of the paw, 2 = strong flinching, 3 = strong flinching and licking) before the surgery (day 0) and at days 3, 7 and 14 after surgery. Data from plantar test were analyzed by two-way repeated measures ANOVA followed by Bonferroni post-hoc test whereas acetone test results were analyzed by Mann-Whitney U-test (***P < 0.001 vs. Sham). All values are expressed as mean ± SEM.
N/OFQ peptide levels
In the same experimental condition, the N/OFQ neuropeptide levels were significantly altered in selected brain areas. In particular, in the ACC of CCI animals, significantly higher levels of ir-N/OFQ levels were observed compared to sham (CCI group = 11.25 ± 1.19 vs. sham mice = 6.88 ± 0.37; t = 3.47, df = 10; P < 0.01; Fig. 3c) . Similarly, an increase of ir-N/OFQ levels was observed in the AMY (CCI group = 13.13 ± 0.66 vs. sham mice = 7.61 ± 0.42; t = 7.08, df = 10; P < 0.001; Fig. 4c ). Neurochemical analysis of changes in pN/OFQ and NOP receptor mRNAs (gene expression) and N/OFQ peptide levels (RIA) in the BS (left panels: a, b and c) and in the TH (right panels: d, e and f) of mice subjected to the CCI and sham operated (SHAM) animals (n = 6 per group), 14 days after surgery. Relative gene expression of pN/OFQ and NOP receptor were calculated by the DDCt method and normalized to the housekeeping gene GAPDH. The N/OFQ peptide levels were calculated as pmol/g of fresh tissue of ir-N/OFQ. Gene expression and RIA data were analyzed by t-test (*P < 0.05, **P < 0.01 vs. SHAM) and are expressed as mean ± SEM.
No significant changes of ir-N/OFQ levels were observed in the BS (Fig. 2c) , the TH (Fig. 2f) , the SSC (Fig. 3f ) and the HYP (Fig. 4f) .
Discussion
N/OFQ-NOP system plasticity phenomena following nerve injury have been investigated more in detail at spinal than supraspinal level (Hao et al. 1998; Mika et al. 2011; Xu et al. 2000) . Here, we explored this system alterations in selected brain areas, in a mouse CCI model of neuropathic pain. The interval chosen for neurochemical analysis was 14 days after surgery when hyperalgesia and allodynia were present and fully developed. In this regard, alterations of NOP receptor mRNA have been reported at day 7 after surgery, and these changes lasted for 2 weeks (Ma et al. 2005) .
Results here reported showed that neuropathic pain conditions affect the N/OFQ-NOP system in selected cerebral regions. The false operation procedure (e.g. anesthesia, tissue injury and wound closure) and the same behavioral testing procedures made the two groups comparable with the only exception represented by the nerve injury.
In particular, we found alterations in the TH, ACC, AMY and HYP after gene expression and RIA analyses. On the contrary, no changes were detected in the BS and SSC.
The BS is a complex brain area comprising several regions, including the periaqueductal gray (PAG) matter and the Brain N/OFQ system and neuropathic pain aspects different nuclei of the rostroventromedial medulla, which activate the endogenous pain control system (Ossipov et al. 2014) . Here, we did not observe any changes of N/OFQ-NOP system in the BS. However, previous study reported an increase of ir-N/OFQ in the PAG of spinal nerve-ligated rats (Sun et al. 2001) . The reason for the discrepancy with our data may be found in the structural complexity of the BS. In fact, the PAG is one of the multiple regions of this area, and our analysis of whole BS could have hindered localized changes.
Recent studies reported that after different types of nerve injury, only patients developing neuropathic pain show functional and chemical alterations of the TH (Boord et al. 2007; Gustin et al. 2014; Henderson et al. 2013; Walton & Llinas 2010) . In particular, neuropathic pain was associated with a reduction in the thalamic inhibitory function and in an increased thalamic outflow to the cortical structures involved in pain processing (Gustin et al. 2014) . Therefore, this altered thalamocortical activity may result in a constant pain perception (Henderson et al. 2013) . A significant decrease of both pN/OFQ and NOP mRNAs was observed in the TH of our neuropathic animals indicating that also the N/OFQ-NOP system is involved in thalamic changes induced by neuropathic pain. According to the inhibitory actions of the N/OFQ-NOP system (Heinricher 2003) it has been shown that N/OFQ, through the NOP receptor activation, reduces the thalamic excitability (Meis et al. 2002) . Hence, the N/OFQ-NOP system gene expression reduction here observed could be related to the pathological decrease of the thalamic inhibitory function as well as to the hypersensitivity showed by CCI animals in plantar and acetone tests. a, b and c) and in the HYP (right panels: d, e and f) of mice subjected to the CCI and sham operated (SHAM) animals (n = 6 per group), 14 days after surgery. Relative gene expression of pN/OFQ and NOP receptor were calculated by the DDCt method and normalized to the housekeeping gene GAPDH. The N/OFQ peptide levels were calculated as pmol/g of fresh tissue of ir-N/OFQ. Gene expression and RIA data were analyzed by t-test (*P < 0.05; ***P < 0.001 vs. SHAM) and are expressed as mean ± SEM.
The major cortical areas receiving thalamic projections are the SSC, ACC and anterior insular cortex (Casey 2000; Casey et al. 1994) . In particular, SSC and ACC play distinct roles in pain processing; in fact, the SSC is involved in the sensory-discriminative aspect of pain perception, and the ACC in the emotional feature of the painful experience (Barthas et al. 2015) . In this regard, human studies revealed that manipulation of pain unpleasantness produced significant changes in the ACC, whereas manipulation of pain intensity mainly affected the SSC (Hofbauer et al. 2001; Rainville et al. 1997 Rainville et al. , 1999 .
Here we observed a marked increase of the N/OFQ peptide level and NOP receptor gene expression in the ACC 14 days after the surgery, whereas no changes in the N/OFQ system occurred in the SSC. This selective cortical alteration might suggest that the N/OFQ-NOP system could be more involved in the emotional than in the sensory-discriminative aspect of neuropathic pain. We acknowledge the limitation of the study in supporting this hypothesis since specific studies on mood alterations were not performed. However, mood alterations have been recently assessed in CCI animals 14 days after nerve lesion (Bravo et al. 2012; Ishikawa et al. 2015) and further on (Alba-Delgado et al. 2013; Caspani et al. 2014) .
Nevertheless, the increase of N/OFQ peptide in the ACC might contribute to the development of typical neuropathic signs here observed in CCI animals, since the complex involvement in the perception of nociceptive signals has been demonstrated for selected ACC neurons (Kang et al. 2015) .
The AMY is a brain region known to play a relevant role in the affective and cognitive dimensions of pain (Veinante et al. 2013; Yalcin et al. 2014) . It receives nociceptive input from the BS and highly processed information from the TH and the cerebral cortex; in addition, the AMY influences the pain control descending pathway (Veinante et al. 2013) .
In our study, CCI mice showed no alterations in the N/OFQ-NOP system gene expression in the AMY, even though a marked increase of N/OFQ peptide content was observed. This increase could be related to the enhanced nociceptive behavior exhibited by CCI animals since it was demonstrated that N/OFQ can affect the regulation of the descending antinociceptive circuitry (Chen et al. 2009 ). In fact, electrophysiological experiments revealed that the N/OFQ (1 μM) perfusion of the central AMY-PAG projection neurons caused the inhibition of the descending pain pathway by the hyperpolarization of CRFergic neurons (Chen et al. 2009 ). Moreover, considering the well-established role of N/OFQ as a functional antagonist for the extrahypothalamic CRF (Ciccocioppo et al. 2001 (Ciccocioppo et al. , 2002 , the increase of N/OFQ peptide in the AMY might also modulate the neuropathic pain emotional consequences (Rouwette et al. 2012; Ulrich-Lai et al. 2006) .
Pain is frequently associated with the activation of the hypothalamo-pituitary-adrenal (HPA) axis (Aubrun et al. 2003) as well as the stress condition can increase the susceptibility to develop pain (Ashkinazi & Vershinina 1999) .
In this study, mice subjected to CCI showed a decrease of pN/OFQ and NOP mRNAs in the HYP, without alterations of N/OFQ peptide levels. N/OFQ is involved in the regulation of the HPA axis activity (Delaney et al. 2012) and it was initially considered as an anti-stress peptide (Köster et al. 1999) . Subsequent studies indicated instead that N/OFQ activates the HPA axis through the NOP receptor (Devine et al. 2001; Leggett et al. 2006 Leggett et al. , 2007 . Depending on the pain type, the HPA axis is differently activated; for example, an increase of corticosterone levels was described in preclinical models of inflammatory pain (Benedetti et al. 2012) , whereas no changes in the function of the HPA axis was observed in neuropathic pain conditions. Therefore, the reduction of the N/OFQ-NOP system gene expression here observed might reflect the lack of HPA axis activation well documented in chronic/neuropathic pain conditions (Bomholt et al. 2005; Bravo et al. 2012; Rouwette et al. 2012; Ulrich-Lai et al. 2006) . Moreover, the absence of N/OFQ peptide alterations well matches with similar results obtained in the HYP of sciatic nerve-injured rats, differently from what observed in the carrageenan-inflammatory pain model (Rosén et al. 2000) .
Thalamic and hypothalamic results, that showed a decrease in pN/OFQ mRNA along with no changes of peptide levels, might indicate the occurrence of a decreased precursor biosynthesis together with an increase of its processing, resulting in unchanged peptide levels.
Similarly, in the AMY and ACC unchanged pN/OFQ gene expression was observed despite the ir-N/OFQ increase. In turn, this result could come up from selective and ordered sequence of endoproteolytic cleavage events and/or following the reduction of N/OFQ peptide degradation (Dores & Baron 2011) . Actually, peptide levels represent steady state measures depending upon the balance among several consecutive processes: gene transcription, mRNA translation, enzymatic processing of the precursor, peptide release and degradation. As a result, the simultaneous occurrence of these different processes might produce unchanged peptide levels, therefore masking actually happened phenomena. Hence, the lack of parallelism between mRNA and peptide levels may not necessarily mean the lack of functional implications (Vogel & Marcotte 2012) . Another explanation of these phenomena could be that the gene expression alterations may have occurred previously, since mRNA changes of the N/OFQ system have been already reported in some areas of rat mesencephalon 7 days after surgery (Ma et al. 2005) .
In conclusion, our data indicate that during neuropathic pain condition selected alterations of the N/OFQ-NOP system take place in brain regions related to the control of pain. In particular, the gene expression downregulation observed in the TH suggests that this system could take part in the alteration of the thalamic inhibitory function which results in an enhanced pain perception. In addition, the selective changes here observed suggest that at cortical level this system could be more involved in the emotional rather than in the sensory-discriminative aspect of neuropathic pain. Thus, it appears that at supraspinal level the N/OFQ-NOP system plays a role in the modulation of pain perception as well as of its emotional components, probably representing a common pathway for these two aspects of the neuropathic pain condition.
